Israel: Antisera Market 2024

Antisera Market Size in Israel

The Israeli antisera market surged to $X in 2021, with an increase of 25% against the previous year. Overall, consumption, however, enjoyed a prominent expansion. As a result, consumption attained the peak level of $X. From 2018 to 2021, the growth of the market failed to regain momentum.

Antisera Production in Israel

In value terms, antisera production amounted to $X in 2021 estimated in export price. Overall, production faced a sharp curtailment. The most prominent rate of growth was recorded in 2017 with an increase of 220%. As a result, production attained the peak level of $X. From 2018 to 2021, production growth failed to regain momentum.

Antisera Exports

Exports from Israel

In 2021, the amount of antisera and other blood fractions exported from Israel declined sharply to X tons, waning by -69.1% compared with the previous year. Overall, exports recorded a deep setback. The most prominent rate of growth was recorded in 2016 when exports increased by 45% against the previous year. As a result, the exports attained the peak of X tons. From 2017 to 2021, the growth of the exports failed to regain momentum.

In value terms, antisera exports reduced sharply to $X in 2021. In general, total exports indicated a moderate increase from 2012 to 2021: its value increased at an average annual rate of +4.5% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2016 when exports increased by 27%. As a result, the exports attained the peak of $X. From 2017 to 2021, the growth of the exports remained at a somewhat lower figure.

Exports by Country

Australia (X tons) was the main destination for antisera exports from Israel, with a 36% share of total exports. Moreover, antisera exports to Australia exceeded the volume sent to the second major destination, South Korea (X tons), threefold. Canada (X tons) ranked third in terms of total exports with a 10% share.

From 2012 to 2021, the average annual rate of growth in terms of volume to Australia stood at +38.2%. Exports to the other major destinations recorded the following average annual rates of exports growth: South Korea (+25.8% per year) and Canada (-1.4% per year).

In value terms, the United States ($X) remains the key foreign market for antisera and other blood fractions exports from Israel, comprising 22% of total exports. The second position in the ranking was taken by Australia ($X), with a 2.6% share of total exports. It was followed by Brazil, with a 1.7% share.

From 2012 to 2021, the average annual growth rate of value to the United States stood at -5.9%. Exports to the other major destinations recorded the following average annual rates of exports growth: Australia (+48.3% per year) and Brazil (-9.3% per year).

Export Prices by Country

In 2021, the average antisera export price amounted to $X per ton, rising by 143% against the previous year. Overall, the export price posted strong growth. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices for the major external markets. In 2021, the country with the highest price was the United States ($X per ton), while the average price for exports to New Zealand ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Russia (+60.1%), while the prices for the other major destinations experienced more modest paces of growth.

Antisera Imports

Imports into Israel

Antisera imports into Israel declined notably to X tons in 2021, which is down by -42.5% compared with 2020. In general, imports, however, recorded prominent growth. The pace of growth was the most pronounced in 2014 when imports increased by 62%. Imports peaked at X tons in 2020, and then declined markedly in the following year.

In value terms, antisera imports rose sharply to $X in 2021. Over the period under review, imports, however, saw significant growth. The most prominent rate of growth was recorded in 2014 with an increase of 113% against the previous year. Imports peaked in 2021 and are likely to see steady growth in the immediate term.

Imports by Country

The United States (X tons), Switzerland (X tons) and Germany (X tons) were the main suppliers of antisera imports to Israel, with a combined 57% share of total imports. Ireland, Japan, the Netherlands, France, China, Austria, Belgium, Italy, Singapore and South Korea lagged somewhat behind, together comprising a further 29%.

From 2012 to 2021, the biggest increases were recorded for Japan (with a CAGR of +86.1%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the United States ($X), Germany ($X) and Switzerland ($X) constituted the largest antisera suppliers to Israel, with a combined 56% share of total imports. These countries were followed by Ireland, China, Italy, France, Belgium, Japan, South Korea, the Netherlands, Singapore and Austria, which together accounted for a further 30%.

China, with a CAGR of +89.5%, recorded the highest rates of growth with regard to the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2021, the average antisera import price amounted to $X per ton, with an increase of 92% against the previous year. In general, the import price enjoyed buoyant growth. As a result, import price attained the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably country of origin: the country with the highest price was Ireland ($X per ton), while the price for Austria ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Belgium (+19.5%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :